Skip to main content
SpringerLink
Log in

Adalimumab/ustekinumab

Latent tuberculosis infection: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Daniel VT, et al. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. Journal of the American Academy of Dermatology 84: 830-833, No. 3, Mar 2021. Available from: URL: http://doi.org/10.1016/j.jaad.2020.09.075

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/ustekinumab. Reactions Weekly 1846, 15 (2021). https://doi.org/10.1007/s40278-021-92263-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92263-9

Search

Navigation